E47 modulates hepatic glucocorticoid action
Glucocorticoids (GCs) are widely used anti-inflammatory drugs; however, long-term treatment causes metabolic side effects. Here, the authors show that E47 is a modulator of glucocorticoid receptor activity for a subset of target genes in mouse liver, and that loss of E47 protects mice from hyperglyc...
Enregistré dans:
Auteurs principaux: | M. Charlotte Hemmer, Michael Wierer, Kristina Schachtrup, Michael Downes, Norbert Hübner, Ronald M. Evans, N. Henriette Uhlenhaut |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c66a0d65c60642e39dc4efc1ae62484e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
par: Erika Harno, et autres
Publié: (2021) -
Modulation by Ozone of Glucocorticoid-Regulating Factors in the Lungs in Relation to Stress Axis Reactivity
par: Jith Thomas, et autres
Publié: (2021) -
Impact of cadmium exposure during pregnancy on hepatic glucocorticoid receptor methylation and expression in rat fetus.
par: Paula Castillo, et autres
Publié: (2012) -
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states
par: Simiao Xu, et autres
Publié: (2021) -
Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α
par: Sara Della Torre, et autres
Publié: (2021)